• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS, INC. THERAKOS CELLEX PHTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS, INC. THERAKOS CELLEX PHTOPHERESIS SYSTEM Back to Search Results
Lot Number C123-KIT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fever (1858); Unspecified Infection (1930); Chills (2191)
Event Date 09/17/2014
Event Type  Injury  
Event Description
Customer reported that a patient had fever, 38.2 degrees c, and chills after treatment and felt very cold.Procedure was normal, there were no alarms.Photoactivation time was long, 99 minutes, due to too many rbc's in the treatment bag.Buffy coat 249 ml, 4.2 ml uvadex.The patient was stable and there were no symptoms during treatment.No additional investigations were planned.Patient left the ecp department to the ward.Clinical services specialist called back the following day: patient received paracetamol 1g, at 14:30, at 19:00 and also during the night at 2:30.It was reported on (b)(6) that the patient received a planned blood transfusion the day before ecp (in another hospital) because of very low hb and hct values.It was reported that this patient receives prbc's each time her b and hct are too low to safely perform ecp.The day after ecp, antibiotic therapy was started due to increased crp values.Nurse could not provide more details.On (b)(6) the physician confirmed the cause of the increased crp was a bladder infection and there was no relationship to ecp.The patient was admitted in the hospital four days longer than initially planned due to this infection longer than initially planned due to this infection - tazobac (penicillin-antibiotkum) was given 3x/day for five days.Patient was fully recovered when she left the hospital.
 
Manufacturer Narrative
Batch record review of lot c123 was conducted.There were no nonconformances related to this complaint associated with this lot.The lot met release requirements.Trends have been reviewed for complaint categories, chills and fever, and no trends were detected for either complaint category.This assessment is based on information available at the time of this report.No product was returned for evaluation; therefore, it could not be determined if this specific product met specifications.This case is being reported due to the patient's prolonged hospitalization with bladder infection.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERAKOS CELLEX PHTOPHERESIS SYSTEM
Type of Device
CELLEX
Manufacturer (Section D)
THERAKOS, INC.
bridgewater NJ
Manufacturer (Section G)
HARMAC MEDICAL PRODUCTS
2201 baily ave.
buffalo NY 14211
Manufacturer Contact
440 us route 22 east
suite 140
bridgewater, NJ 08807
MDR Report Key4171986
MDR Text Key16849416
Report Number2523595-2014-00263
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P680003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Nurse
Type of Report Initial
Report Date 09/17/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/01/2016
Device Lot NumberC123-KIT
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/17/2014
Initial Date FDA Received10/10/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/01/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age74 YR
Patient Weight63
-
-